Noom vs Vaylen
Noom and Vaylen both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Vaylen
Best for: bloodwork inside the $179/month rather than billed on top
Visit Vaylen →If you are choosing between Noom and Vaylen, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Vaylen leads our six-part score, 8.2 to 6.9.
Noom vs Vaylen price
Noom and Vaylen start at the same figure, $179 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Semaglutide costs the same at both, $179 a month; tirzepatide is cheaper at Vaylen ($239 a month vs $349 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format they match: each offers compounded injections and brand-name pens.
Where each one treats patients
Noom does not publish where it ships, and Vaylen lists 50 states.
Pricing
Noom
The first 3 weeks of the program with 4 weeks of medication start from $149, then $349 per month plus tax on a 12-week subscription. The program also offers generic liraglutide.
The first 3 weeks with 4 weeks of medication start from $79, then $179 per month plus tax on a 12-week subscription. Compounded tirzepatide is also offered on this plan.
Vaylen
What each price covers
Both prices cover the clinician visit and coaching.
Vaylen's price also covers the medication itself, shipping and lab work, which Noom does not claim.
Noom is silent on the medication itself, shipping and lab work.
That matters most for the drug: unless Noom confirms otherwise, budget for medication on top of its listed price.
Noom
Covered by the monthly price
Medication
Not stated
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Vaylen
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
In the price
Coaching
In the price
Where each one scores higher
Overall, Vaylen scores 8.2 and Noom 6.9 out of 10.
Noom is stronger on user experience (8.0 vs 7.5).
Vaylen is stronger on trust & safety (8.5 vs 6.5), accessibility (10.0 vs 5.0) and support (10.0 vs 4.0).
Value and effectiveness are within half a point.
Noom
6.9/10
Vaylen
8.2/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Noom nor Vaylen has an FDA warning letter on record with us.
Features & Coverage
| Feature | Noom | Vaylen |
|---|---|---|
| Starting Price | $179/mo | $179/mo |
| Features | 2 features | ✓8 features |
| States Available | Not disclosed | 50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Noom
Noom is a behavioral weight loss app. It also prescribes GLP-1 medications through Noom Med.
Read our full Noom review →About Vaylen
Vaylen is a pure GLP-1 specialist: compounded semaglutide at $179/mo, compounded tirzepatide at $239/mo, a compounded oral GLP-1 at $259/mo, and brand-name Ozempic, Zepbound, and Wegovy. LegitScript certified, with licensed clinicians in all 50 states.
Read our full Vaylen review →Pros & Cons
Noom
What we like
- Semaglutide costs $179 a month, close to the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $349 a month, 72% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits and coaching
- We found no FDA warning letters issued to Noom
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Vaylen
What we like
- Semaglutide costs $179 a month, close to the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $239 a month, close to the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits, shipping, lab work and coaching
- Serves all 50 states
- We found no FDA warning letters issued to Vaylen
- Baseline bloodwork is required before a prescription
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Vaylen wins this one, 8.2 to 6.9, above all for bloodwork inside the $179/month rather than billed on top. Noom fits better if coaching bundled into the price rather than sold separately is your priority.
Choose Noom if…
You want coaching bundled into the price rather than sold separately and an opening price near $179 a month.
Choose Vaylen if…
You want bloodwork inside the $179/month rather than billed on top and an opening price near $179 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Eden
Coverage in all 50 states, which most sellers will not confirm
From $239/mo
Get started →SnagRx
Semaglutide at $99/month, 48% below the typical price
From $99/mo
Get started →Embody
Knowing which pharmacy fills the vial: it names RedRock Pharmacy
From $79/mo
Get started →Noom vs Vaylen: FAQ
Close alternatives to Noom and Vaylen
- Noom vs GOAL.MD
- Noom vs DudeMeds
- Noom vs Healthicare
- Vaylen vs GOAL.MD
- Vaylen vs DudeMeds
- Vaylen vs Healthicare
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.